80 related articles for article (PubMed ID: 27531222)
1. Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697.
Hirota-Takahata Y; Kurosawa E; Ishimoto Y; Iwadate Y; Kizuka M; Chiba J; Hasegawa T; Tanaka M; Kobayashi H
J Antibiot (Tokyo); 2017 Feb; 70(2):179-186. PubMed ID: 27531222
[TBL] [Abstract][Full Text] [Related]
2. A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF.
Ishimoto Y; Hirota-Takahata Y; Kurosawa E; Chiba J; Iwadate Y; Onozawa Y; Hasegawa T; Tamura A; Tanaka M; Kobayashi H
Cell Physiol Biochem; 2016; 39(5):1905-1918. PubMed ID: 27771716
[TBL] [Abstract][Full Text] [Related]
3. F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414.
Hirota-Takahata Y; Ishimoto Y; Kurosawa E; Iwadate Y; Onozawa Y; Tanaka I; Tanaka M; Kobayashi H
J Antibiot (Tokyo); 2017 Oct; 70(10):981-986. PubMed ID: 28792011
[TBL] [Abstract][Full Text] [Related]
4. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
[TBL] [Abstract][Full Text] [Related]
5. JBIR-69, a new metabolite from Streptomyces sp. OG05.
Fujiwara T; Nagai A; Takagi M; Shin-ya K
J Antibiot (Tokyo); 2010 Feb; 63(2):95-6. PubMed ID: 20075978
[No Abstract] [Full Text] [Related]
6. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
[TBL] [Abstract][Full Text] [Related]
7. A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405.
Fujita Y; Kizuka M; Funabashi M; Ogawa Y; Ishikawa T; Nonaka K; Takatsu T
J Antibiot (Tokyo); 2011 Jul; 64(7):495-501. PubMed ID: 21587261
[TBL] [Abstract][Full Text] [Related]
8. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells.
Omura S; Fujimoto T; Otoguro K; Matsuzaki K; Moriguchi R; Tanaka H; Sasaki Y
J Antibiot (Tokyo); 1991 Jan; 44(1):113-6. PubMed ID: 1848215
[No Abstract] [Full Text] [Related]
9. Piceamycin and its N-acetylcysteine adduct is produced by Streptomyces sp. GB 4-2.
Schulz D; Nachtigall J; Riedlinger J; Schneider K; Poralla K; Imhoff JF; Beil W; Nicholson G; Fiedler HP; Süssmuth RD
J Antibiot (Tokyo); 2009 Sep; 62(9):513-8. PubMed ID: 19609293
[TBL] [Abstract][Full Text] [Related]
10. [Biosynthesis of nactinic compounds by population variants of macrotetrolide-producing streptomycetes].
Sverdlova AN; Zaretskaia MSh; Solov'eva LN; Vinogradova KA; Konoshenko GI
Antibiot Khimioter; 1996 Jun; 41(6):3-9. PubMed ID: 9054326
[TBL] [Abstract][Full Text] [Related]
11. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. II. Physico-chemical properties and structure elucidation.
Fujita Y; Murakami R; Muramatsu Y; Miyakoshi S; Takatsu T
J Antibiot (Tokyo); 2008 Sep; 61(9):545-9. PubMed ID: 19160521
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of lactacystin.
Takahashi S; Uchida K; Nakagawa A; Miyake Y; Kainosho M; Matsuzaki K; Omura S
J Antibiot (Tokyo); 1995 Sep; 48(9):1015-20. PubMed ID: 7592046
[TBL] [Abstract][Full Text] [Related]
13. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.
Fukumoto A; Kim YP; Iwatsuki M; Hirose T; Sunazuka T; Hanaki H; Ōmura S; Shiomi K
J Antibiot (Tokyo); 2017 May; 70(5):568-573. PubMed ID: 28293036
[TBL] [Abstract][Full Text] [Related]
14. Studies on novel HIF activators, A-503451s.I. Producing organism, fermentation, isolation and structural elucidation.
Hirota-Takahata Y; Kobayashi H; Kizuka M; Ohyama T; Kitamura-Miyazaki M; Suzuki Y; Fujiwara M; Nakajima M; Ando O
J Antibiot (Tokyo); 2016 Oct; 69(10):747-753. PubMed ID: 26956789
[TBL] [Abstract][Full Text] [Related]
15. Quinomycins H1 and H2, new cytotoxic antibiotics from Streptomyces sp. RAL404.
Hayakawa Y; Sone R; Aoki H; Kimata S
J Antibiot (Tokyo); 2018 Oct; 71(10):898-901. PubMed ID: 30018424
[TBL] [Abstract][Full Text] [Related]
16. The effects of sugars and nitrogenous compounds upon the metabolism of Streptomyces aureofaciens.
CHANG SL
Sci Sin; 1961 Jul; 10():349-60. PubMed ID: 13692339
[No Abstract] [Full Text] [Related]
17. Ogipeptins, novel inhibitors of LPS: physicochemical properties and structural elucidation.
Hirota-Takahata Y; Kozuma S; Kuraya N; Fukuda D; Nakajima M; Takatsu T; Ando O
J Antibiot (Tokyo); 2017 Jan; 70(1):84-89. PubMed ID: 27328866
[TBL] [Abstract][Full Text] [Related]
18. Influence of carbon & nitrogen sources on the biosynthesis of litmocidin by a new strain of Streptomyces litmocidini.
Abou-Zeid AZ
Indian J Exp Biol; 1970 Jul; 8(3):231-2. PubMed ID: 5494288
[No Abstract] [Full Text] [Related]
19. Synthesis and Structural Revision of Cyslabdan.
Ohtawa M; Hishinuma Y; Takagi E; Yamada T; Ito F; Arima S; Uchida R; Kim YP; Ōmura S; Tomoda H; Nagamitsu T
Chem Pharm Bull (Tokyo); 2016; 64(9):1370-7. PubMed ID: 27581641
[TBL] [Abstract][Full Text] [Related]
20. Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete.
Stadler M; Bitzer J; Mayer-Bartschmid A; Müller H; Benet-Buchholz J; Gantner F; Tichy HV; Reinemer P; Bacon KB
J Nat Prod; 2007 Feb; 70(2):246-52. PubMed ID: 17249727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
